AvataCore
AvataCore is a telehealth platform operated by AvataCore, LLC. The company states it is not itself a pharmacy, healthcare provider, or insurance company: clinical services, including provider consultations, medical evaluations, and prescribing decisions, are handled by OpenLoop Health, a network of independently licensed U.S. healthcare providers who retain full authority over prescribing decisions. AvataCore offers compounded GLP-1 weight-loss medication in three formats: a weekly compounded semaglutide injection, a daily oral compounded semaglutide tablet, and a weekly compounded semaglutide/tirzepatide (GLP-1/GIP) dual-action injection. AvataCore states compounded medications are not FDA-approved and differ from FDA-approved branded products in formulation, strength, inactive ingredients, and clinical effects.